2017
DOI: 10.1016/j.anndiagpath.2017.05.009
|View full text |Cite
|
Sign up to set email alerts
|

Chronic inflammation in refractory hippocampal sclerosis-related temporal lobe epilepsy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
25
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 33 publications
(29 citation statements)
references
References 30 publications
1
25
0
Order By: Relevance
“…Neuronal apoptosis and inflammatory response play critical roles in the development of epilepsy [6,25]. Chronic inflammation is a common component of hippocampal sclerosis-associated temporal lobe epilepsy [26]. miRNA is a novel regulator of the pathogenesis of temporal lobe epilepsy, which can have important effects on neuronal apoptosis, as well as affecting immune and inflammatory processes [15].…”
Section: Discussionmentioning
confidence: 99%
“…Neuronal apoptosis and inflammatory response play critical roles in the development of epilepsy [6,25]. Chronic inflammation is a common component of hippocampal sclerosis-associated temporal lobe epilepsy [26]. miRNA is a novel regulator of the pathogenesis of temporal lobe epilepsy, which can have important effects on neuronal apoptosis, as well as affecting immune and inflammatory processes [15].…”
Section: Discussionmentioning
confidence: 99%
“…We chose to study the pilocarpine model in the latent phase, which comprises the period where epileptogenesis occurs (Löscher & Brandt, 2010;Pitkänen et al, 2007). Although previous studies have identified several mechanisms that participate in this phenomenon (Cho et al, 2015;Cloix & Hévor, 2009;Devinsky, Vezzani, Najjar, De Lanerolle, & Rogawski, 2013;Gales & Prayson, 2017;Parent et al, 1997;Ravizza, Balosso, & Vezzani, 2011;Rowley & Patel, 2013), all of these studies are hypothesis-driven and, therefore, biased toward the specific mechanism they sought to investigate. In the present study, we adopted two high throughput agnostic approaches capable of providing a view of the biological interactions occurring during the epileptogenic process in the pilocarpine model of MTLE.…”
Section: Discussionmentioning
confidence: 99%
“…An inflammatory response is frequently implicated in several neurological disorders (Akiyama et al, 2000;Chen et al, 2018;Crotti & Glass, 2015;Onore, Careaga, & Ashwood, 2012;Ray, Juranek, & Rai, 2016), including epilepsy (Devinsky et al, 2013;Gales & Prayson, 2017); however, it is often unclear whether inflammation is related to the cause or is a consequence of the pathological mechanism underlying these disorders. Here, we identified several upregulated pathways involved with inflammation, and the immune response in all areas and sub-fields analyzed.…”
Section: Discussionmentioning
confidence: 99%
“…CB2Rs play a well-documented role in reducing neuroinflammation in mouse models of neurological disease. 65,66 Given the reduction in inflammation that is observed following CB2R activation, treatments targeting CB2R might prove to be particularly efficacious in epilepsy disorders like MTLE. [60][61][62] This reduction in neuroinflammation has been associated with improved outcomes in these models.…”
Section: Discussionmentioning
confidence: 99%
“…[62][63][64] Several forms of drug-resistant epilepsy, such as mesial temporal lobe epilepsy (MTLE), are characterized by high levels of neuroinflammation. 65,66 Given the reduction in inflammation that is observed following CB2R activation, treatments targeting CB2R might prove to be particularly efficacious in epilepsy disorders like MTLE.…”
Section: Discussionmentioning
confidence: 99%